UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Effect of Dietary Macronutrient Composition

Not Applicable

Completed

Conditions: Metabolic Syndrome
Obesity
Non-alcoholic Fatty Liver Disease

Interventions: Other: Low-fat diet
Other: Low-carbohydrate diet

First Posted Date: 2011-06-10

Last Posted Date: 2019-02-06

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 24

Registration Number: NCT01371396

Locations: 🇺🇸
Center for Human Nutrition, Dallas, Texas, United States

Effects of IGF-I in HIV Metabolic Disease

Phase 1

Terminated

Conditions: HIV Lipodystrophy

Interventions: Drug: Placebo control
Drug: mecasermin

First Posted Date: 2011-04-06

Last Posted Date: 2016-03-23

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 16

Registration Number: NCT01329744

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Antidepressant Treatment at an Inner City Asthma Clinic

Phase 4

Completed

Conditions: Depression
Asthma

First Posted Date: 2011-03-29

Last Posted Date: 2018-05-22

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 139

Registration Number: NCT01324700

Locations: 🇺🇸
Parkland Health and Hospital System (Asthma, Allergy, & Arthritis Clinics), Dallas, Texas, United States

Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers

Phase 1

Completed

Conditions: Sports Concussion

Interventions: Drug: Placebo
Drug: Resveratrol

First Posted Date: 2011-03-23

Last Posted Date: 2021-02-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 12

Registration Number: NCT01321151

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma

Phase 1

Withdrawn

Conditions: Stage II Rectal Cancer
Stage III Rectal Cancer

Interventions: Drug: Capecitabine
Drug: 5-FU
Drug: Leucovorin
Drug: Oxaliplatin
Radiation: radiation
Procedure: total mesorectal excision

First Posted Date: 2011-02-24

Last Posted Date: 2020-08-20

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT01302613

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Metastatic Cancer
Lung Cancer

Interventions: Combination Product: (Erlotinib plus Romidepsin (8mg/m^2)) + Antiemetic prophylaxis
Combination Product: Erlotinib plus Romidepsin (10 mg/m^2)
Combination Product: Erlotinib plus Romidepsin (8 mg/m^2)
Combination Product: Erlotinib plus Romidepsin (10 mg/m^2) + Antiemetic prophylaxis

First Posted Date: 2011-02-24

Last Posted Date: 2021-01-20

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 17

Registration Number: NCT01302808

Locations: 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Reliability and Diagnostic Accuracy of an Alternate Lachman's Test Performed in a Prone Position

Completed

Conditions: Anterior Cruciate Ligament Stability

First Posted Date: 2011-02-23

Last Posted Date: 2016-05-17

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 57

Registration Number: NCT01301014

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis

Not Applicable

Terminated

Conditions: Moderate to Severe Atopic Dermatitis

Interventions: Other: Dilute bleach baths
Other: Water

First Posted Date: 2011-01-31

Last Posted Date: 2020-03-20

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 27

Registration Number: NCT01286220

Locations: 🇺🇸
Children's Medical Center of Dallas, Dallas, Texas, United States

Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.

Not Applicable

Completed

Conditions: Portosystemic Encephalopathy
PSE
Hepatic Encephalopathy
Cirrhosis

Interventions: Drug: Polyethylene glycol 3350-electrolyte solution (GoLYTELY®)
Drug: Lactulose

First Posted Date: 2011-01-25

Last Posted Date: 2014-12-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 50

Registration Number: NCT01283152

Locations: 🇺🇸
University of Texas Southwestern Medical Center and Parkland Memorial Health and Hospital System, Dallas, Texas, United States

Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment

Phase 4

Completed

Conditions: Administration Site Reaction

Interventions: Drug: Fentanyl

First Posted Date: 2011-01-17

Last Posted Date: 2013-03-15

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 100

Registration Number: NCT01277861

Locations: 🇺🇸
Ut Southwestern Medical Center At Dallas, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy